» Articles » PMID: 8495317

Obesity: an Important Prognostic Factor in Acute Pancreatitis

Overview
Journal Br J Surg
Specialty General Surgery
Date 1993 Apr 1
PMID 8495317
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Ninety-nine patients with acute pancreatitis in whom body mass index (BMI = weight (kg)/height2 (m2)) was measured were studied prospectively to determine the importance of obesity as a prognostic factor in this disease. Of 19 obese patients (BMI > or = 30 kg/m2), 12 developed severe pancreatitis; seven had abscesses, of whom five died, and two further patients died. In 80 non-obese patients, the incidence of severe pancreatitis (n = 5), abscess formation (n = 4) and death (n = 4) was significantly less (P = 0.0007). The mean(s.d.) BMI of 17 patients with severe acute pancreatitis was significantly higher than that in 82 patients with mild acute disease (31.2(5.6) versus 23.3(5.6) kg/m2, P < 0.001). As a single prognostic factor, obesity had a sensitivity of 63 per cent and a specificity of 95 per cent for predicting disease severity. When five obese women with gallstone pancreatitis were excluded, the sensitivity of obesity increased to 86 per cent. Severe pancreatitis occurred in all eight obese patients with disease of an alcoholic aetiology. These data suggest that increased fat deposits in the peripancreatic and retroperitoneal spaces in obese patients may increase the risk of peripancreatic fat necrosis, abscess and death. Consideration should be given to including obesity as a prognostic factor in acute pancreatitis.

Citing Articles

Metabolites and Lipoproteins May Predict the Severity of Early Acute Pancreatitis in a South African Cohort.

Mazibuko J, Elebo N, Williams A, Omoshoro-Jones J, Devar J, Smith M Biomedicines. 2024; 12(11).

PMID: 39594998 PMC: 11592248. DOI: 10.3390/biomedicines12112431.


Investigating potential biomarkers of acute pancreatitis in patients with a BMI>30 using Mendelian randomization and transcriptomic analysis.

Ji H, Tang Z, Jiang K, Lyu S, Zhao Y, Feng J Lipids Health Dis. 2024; 23(1):119.

PMID: 38649912 PMC: 11034057. DOI: 10.1186/s12944-024-02102-3.


Nonalcoholic fatty pancreas disease: An emerging clinical challenge.

Zhang C, Wang J, Li J, Yang Y World J Clin Cases. 2021; 9(23):6624-6638.

PMID: 34447810 PMC: 8362510. DOI: 10.12998/wjcc.v9.i23.6624.


Leukocyte cell population data from the blood cell analyzer as a predictive marker for severity of acute pancreatitis.

Wang Y, Xu Z, Zhou Y, Xie M, Qi X, Xu Z J Clin Lab Anal. 2021; 35(7):e23863.

PMID: 34062621 PMC: 8274994. DOI: 10.1002/jcla.23863.


The association of parameters of body composition and laboratory markers with the severity of hypertriglyceridemia-induced pancreatitis.

Chen L, Huang Y, Yu H, Pan K, Zhang Z, Man Y Lipids Health Dis. 2021; 20(1):9.

PMID: 33573658 PMC: 7879630. DOI: 10.1186/s12944-021-01443-7.